Identification of novel serotonin transporter (SERT) inhibitors via large-scale machine learning-based virtual screening and molecular dynamics simulations
Molecular Diversity · 28.08.2026 · 30 (6) · 10755-10769
DOI: 10.1007/s11030-026-11705-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, online erschienen am 28.08.2026. Verfasst von Rujia Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, 311200, China. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Serotonin Plasma Membrane Transport Proteins, Machine Learning, Selective Serotonin Reuptake Inhibitors. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The serotonin transporter (SERT) plays a pivotal role in inflammatory responses and is a central therapeutic target for depression. Consequently, identifying potent SERT inhibitors remains a high priority in early-stage drug discovery. In this study, we evaluated twelve regression models, among which LightGBM, Random Forest, and XGBoost exhibited superior predictive performance, yielding R2 values of 0.7138, 0.7001, and 0.6920, respectively. Leveraging these optimized machine learning models, we conducted a large-scale virtual screening of over 11.5 million compounds, identifying 24 promising candidates. Subsequent molecular dynamics (MD) simulations and MM/GBSA binding free energy calculations supported the structural stability and strong predicted binding affinities of three lead molecules: Z2215663922, 19,835,875, and Z310319934. Furthermore, ADMET profiling indicated generally acceptable pharmacokinetic properties, although potential hERG-related liabilities for certain candidates warrant further experimental scrutiny. Our findings provide structurally diverse scaffolds and a computational prioritization framework for early-stage discovery and optimization of SERT inhibitor candidates that merit subsequent experimental validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, 311200, China.
- The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314000, China.
- The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, 311200, China. huangtongzhou@wmu.edu.cn.
Zitieren
APA
Zhao, R., Shen, T., & Huang, T. (2026). Identification of novel serotonin transporter (SERT) inhibitors via large-scale machine learning-based virtual screening and molecular dynamics simulations. Molecular Diversity, 30(6), 10755-10769. https://doi.org/10.1007/s11030-026-11705-0
Vancouver
Zhao R, Shen T, Huang T. Identification of novel serotonin transporter (SERT) inhibitors via large-scale machine learning-based virtual screening and molecular dynamics simulations. Molecular Diversity. 2026;30(6):10755-10769. doi:10.1007/s11030-026-11705-0
BibTeX
@article{Zhao2026,
author = {Zhao, Rujia and Shen, Tianzhu and Huang, Tongzhou},
title = {Identification of novel serotonin transporter (SERT) inhibitors via large-scale machine learning-based virtual screening and molecular dynamics simulations},
journal = {Molecular Diversity},
year = {2026},
volume = {30},
number = {6},
pages = {10755--10769},
doi = {10.1007/s11030-026-11705-0}
}
EUVIMED